Roche Holding AG
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
- Introduction
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Containing Mycophenolate Mofetil
- Conditions
- Kidney Transplantation
- Interventions
- Drug: Immunosuppressive Therapy
- First Posted Date
- 2012-08-27
- Last Posted Date
- 2016-10-11
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 128
- Registration Number
- NCT01672957
A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2012-08-27
- Last Posted Date
- 2016-03-28
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 291
- Registration Number
- NCT01672970
A Non-Interventional Study Evaluating Rheumatoid Arthritis Participants Treated With Tocilizumab (RoActemra/Actemra)
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2012-08-23
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 80
- Registration Number
- NCT01671059
- Locations
- 🇷🇸
Military Medical Academy; Clinic of Rheumatology, Belgrade, Serbia
🇷🇸Institut Za Reumatologiju; Reumatologiju, Belgrade, Serbia
🇷🇸Institute of Rheumatology and Cardiovascular Diseases; Rheumatology, Niska Banja, Serbia
An Observational Study To Assess Liver Fibrosis Stages in Patients With Chronic Hepatitis C Infection
- Conditions
- Hepatitis C, Chronic
- First Posted Date
- 2012-08-23
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 123
- Registration Number
- NCT01671046
A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis
- First Posted Date
- 2012-08-21
- Last Posted Date
- 2016-10-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 43
- Registration Number
- NCT01670045
A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome
- Conditions
- Healthy Volunteer, Autistic Disorder, Asperger's Syndrome
- First Posted Date
- 2012-08-21
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 38
- Registration Number
- NCT01669889
An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2012-08-21
- Last Posted Date
- 2015-11-23
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 107
- Registration Number
- NCT01669902
A Long Term Extension Study of WA19926 (NCT01007435) of Tocilizumab (RoActemra/Actemra) in Participants With Early, Moderate to Severe Rheumatoid Arthritis (RA)
- First Posted Date
- 2012-08-20
- Last Posted Date
- 2019-05-13
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 23
- Registration Number
- NCT01668966
- Locations
- 🇧🇷
Centro de Estudos em Terapias Inovadoras - CETI, Curtiba, PR, Brazil
🇧🇷CIP - Centro Internacional de Pesquisa, Goiania, GO, Brazil
🇧🇷Hospital Sao Lucas - PUCRS, Porto Alegre, RS, Brazil
A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma
- First Posted Date
- 2012-08-17
- Last Posted Date
- 2019-07-23
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 498
- Registration Number
- NCT01667419
- Locations
- 🇷🇺
Krasnodar City Oncology Center, Krasnodar, Russian Federation
🇷🇸Military Medical Academy, Belgrade, Serbia
🇿🇦Mary Potter Oncology Centre, Groenkloof, South Africa
An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2012-08-17
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 59
- Registration Number
- NCT01667458